Foamix Pharmaceuticals Ltd. Derivative Asset
Foamix Pharmaceuticals Ltd. had Derivative Asset of $3.00 thousand as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2019-02-28
- 2018-12-31: Derivative Asset $3.00K.
- 2017-12-31: Derivative Asset $11.00K.
- 2017-06-30: Derivative Asset $25.00K.
| Period end | Derivative Asset |
|---|---|
| 2018-12-31 | $3.00K 10-K · filed 2019-02-28 |
| 2017-12-31 | $11.00K 10-K · filed 2018-03-01 |
| 2017-06-30 | $25.00K 6-K · filed 2017-08-08 |